Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Angiodynamics (ANGO) Return on Equity (2016 - 2025)

Angiodynamics (ANGO) has disclosed Return on Equity for 15 consecutive years, with 0.16% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Return on Equity rose 102.0% year-over-year to 0.16%, compared with a TTM value of 0.16% through Nov 2025, up 102.0%, and an annual FY2025 reading of 0.17%, up 46.0% over the prior year.
  • Return on Equity was 0.16% for Q4 2025 at Angiodynamics, up from 0.18% in the prior quarter.
  • Across five years, Return on Equity topped out at 0.02% in Q3 2023 and bottomed at 1.21% in Q3 2024.
  • Average Return on Equity over 5 years is 0.27%, with a median of 0.09% recorded in 2022.
  • The sharpest move saw Return on Equity crashed -122bps in 2024, then soared 103bps in 2025.
  • Year by year, Return on Equity stood at 0.09% in 2021, then rose by 10bps to 0.08% in 2022, then soared by 57bps to 0.03% in 2023, then tumbled by -3343bps to 1.17% in 2024, then soared by 87bps to 0.16% in 2025.
  • Business Quant data shows Return on Equity for ANGO at 0.16% in Q4 2025, 0.18% in Q3 2025, and 0.18% in Q2 2025.